Just published: cardiac arrest subanalysis of ECLS-SHOCK ahajournals.org/doi/full/10.11… ⁦Janine Pöss⁩ ⁦Christian Hassager⁩ ⁦Christian Jung⁩

In a pre-specified analysis of ILUMIEN IV, XIENCE demonstrated safety and efficacy in the treatment of single-layer ISR, with a 1-year target lesion failure rate of 7.4%. #AHAJournals Ziad Ali Gregg W. Stone MD ahajrnls.org/3SYsJGy

Proud to include the first patient in the EBC DCB study. Soledad Ojeda Javier Suarez d Lezo Javi Moreiras Belén Cid Alvarez Nieves Gonzalo ACI-SEC: Hemodinamica Rafael González Manzanares FRANCESCO BURZOTTA Neisser M Evandro Martins F. MD Goran Stankovic, MD, PhD @davidhild David Hildick-Smith Alfonso Jurado-Román jose diaz Pablo J. Baglioni 🇦🇷 Antonio Gomez Menchero PCRonline 🫀

NCL plaques and prognosis by clinical presentation David Erlinge Gregg W. Stone MD Ole Fröbert Ziad Ali Pernille Gro Thrane Michael Maeng ahajournals.org/doi/full/10.11…

Our new PROSPECT II study in Circulation comparing untreated non-obstructive lsns in STEMI & NSTEMI. ~4 such lsns per pt. 2-feature high-risk plaques were equally present (in 38.8% vs. 32.7%; P=0.11). 4-yr rates of untreated lesion-related MACE were also similar (8.6% vs 7.8%).

In denovo treated with #DCB 🔑 predict #TLF 🟠#HDialysis 🟡severely #calcified 🔴absence of #MedialDissection Full paper 👉ow.ly/S6Ou50SNiZI Hady Lichaa, MD, FACC, FSCAI, FSVM, RPVI Matthias Götberg Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 MIЯVΛƬ #IC jedicath աǟզǟʀ.ǟɦʍɛɖ Dimitri Zappi, M.D. Dr. Krzysztof Pujdak Matthias Bossard 🇺🇦 Matus Stankovic 🇺🇦 Evandro Martins F. MD

Worsening renal function after MRA initiation in HF may signal different risk depending on EF, with MRA benefit in HFrEF despite ERF and in HFpEF only if renal function is stable. #AHAJournals Yudai Fujimoto, MD Yuya Matsue ahajrnls.org/40I4eSe

In the HELP-PCI trial, unfractioned heparin given before Cath Lab arrival improved spontaneous IRA recanalization in STEMI. Is pretreatment making a comeback?Mamas A. Mamas Dr. Deepak L. Bhatt John Mandrola, MD David J. Cohen, MD, MSc MIЯVΛƬ #IC ༄ ｡° C. Michael Gibson MD jedicath աǟզǟʀ.ǟɦʍɛɖ Francesco Costa Hany Ragy Borja Ibanez European Society of Cardiology

Larger and longer stents. Outcomes for Image-Guided PCI in Contemporary Practice. Is there a price to pay? #Cardiotwitter #AHAJournals Devraj Sukul, MD MS Thomas Basala Ryan Madder Brett Wanamaker Brittany Fuller MD Evan Shlofmitz Chadi Alraies, MD FACC FSCAI Amir Kaki, MD Sunil V. Rao ahajrnls.org/4naWK31

New #REVIVED imaging *head to head*: CMR vs echo 🫀 🔺CMR volumes were higher + LVEF was lower 🔺ESVi was predictive of outcomes, LVEF was not 🚨Only 7.5% of paired LVEF values fell within 5% of each other! 🚨A third had CMR LVEF<35% and echo LVEF≥35% academic.oup.com/ehjcimaging/ar…

Because of many non-inferiority trials reported at #ESCCongress2025, this summary below can be helpful to remind you of the interpretation of non-inferiority trial results. I have to review chart every time. 🥸 I hope it is helpful. 👇

New histopathology reveals: calcified nodules with exposed luminal surfaces and plaque fissures could be under‐recognized triggers in coronary events. Might change how we spot and treat vulnerable plaques? Read more in #EHJ. doi.org/10.1093/eurhea… #cardiotwitter European Society of Cardiology Journals

Australian ACS guidelines 2025 - The OMI has officially arrived! - ED Guidelines. edguidelines.com/australian-acu… edguidelines.com/acs-guidelines…

In our latest JACC Journals article, we show that IVI-guided PCI reduces MACE in both men & women—with no sex interaction. Yet, women remain underrepresented in IVI trials (23.9%). It’s time to close the gap. jacc.org/doi/10.1016/j.…

Ten-year outcome in the NOBLE trial 🫀Today, we presented that there is no difference in all-cause mortality ten years after randomization to PCI or CABG in patients with unprotected LMCA disease. For more info contact Evald Høj Christiansen or me - always eager to interact!

We all know that it's not just mortality though, need to also think about re-infarction and rpt revasc. The most interesting slide was the one of PCI with and without imaging vs cabg

The LMCA saga continued! 🔭In the OCTOBER trial, OCT guided PCI in true LM bifurcations was associated with a non-significant improvement in MACE - following the main trial. 🔥Even tough the LMCA ostium was difficult to visualize, USD in the edge was frequent! #TCT2025

Simultaneously published with its presentation at #TCT2025 The IVUS-ACS Trial shows that IVUS-guided PCI markedly improves outcomes in ACS, especially for high-risk patients defined by the new TVF-ACS Risk-Score. A major step forward in precision interventional cardiology. 🔗

In this post hoc analysis of patients with acute coronary syndromes in the OCCUPI trial, the primary outcome—1-year composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularisation—occurred in 4.9% of the OCT-guided group

Inaugural #DCBClub meeting just has commenced in an antiquated lecture hall of Charite Berlin! A new family of interventional cardiologist is evolving … Bruno Scheller Franz Kleber Ton Waksman Antonio Colombo Simon Eccleshall Peter O’Kane Mila Kovacevic Helen Routledge